Search hospitals > California > Duarte
City of Hope Comprehensive Cancer Center
Claim this profileDuarte, California 91010
Global Leader in Cancer
Global Leader in Lymphoma
Conducts research for Leukemia
Conducts research for Tumors
Conducts research for Breast Cancer
2114 reported clinical trials
153 medical researchers
Summary
City of Hope Comprehensive Cancer Center is a medical facility located in Duarte, California. This center is recognized for care of Cancer, Lymphoma, Leukemia, Tumors, Breast Cancer and other specialties. City of Hope Comprehensive Cancer Center is involved with conducting 2,114 clinical trials across 1,082 conditions. There are 153 research doctors associated with this hospital, such as Daneng Li, MD, Anna Pawlowska, MD, Mark Agulnik, and Abhishek Tripathi, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lymphoma
Global LeaderStage IV
Stage II
Stage I
Top PIs
Daneng Li, MDCity of Hope4 years of reported clinical research
Expert in Cancer
Expert in Hepatocellular Carcinoma
27 reported clinical trials
42 drugs studied
Anna Pawlowska, MDCity of Hope Comprehensive Cancer Center7 years of reported clinical research
Expert in Leukemia
Studies Lymphoma
26 reported clinical trials
63 drugs studied
Mark AgulnikCity of Hope4 years of reported clinical research
Studies Sarcoma
Studies Tumors
23 reported clinical trials
34 drugs studied
Abhishek Tripathi, MDUniversity of Oklahoma Health Sciences Center3 years of reported clinical research
Expert in Cancer
Expert in Bladder Cancer
21 reported clinical trials
44 drugs studied
Clinical Trials running at City of Hope Comprehensive Cancer Center
Breast Cancer
Prostate Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Renal Cell Carcinoma
Ovarian Cancer
Leukemia
Lymphoma
Multiple Myeloma
Sacituzumab Govitecan + Pembrolizumab
for Triple-Negative Breast Cancer
This trial compares the effectiveness of a combination of two drugs, SG and pembrolizumab, in patients with advanced triple-negative breast cancer. SG targets and kills cancer cells with chemotherapy, while pembrolizumab helps the immune system attack the cancer. Pembrolizumab has been shown to improve survival in various cancers, including triple-negative breast cancer, when used alone or in combination with other treatments.
Recruiting4 awards Phase 3
Investigational Scan
for Breast Cancer
This clinical trial examines an investigational scan (64Cu-DOTA-trastuzumab positron emission tomography \[PET\]/magnetic resonance imaging \[MRI\]) in imaging patients with HER2+ breast cancer that has spread to the brain (brain metastasis). Diagnostic procedures, such as 64Cu-DOTA-trastuzumab PET/MRI, may help find HER2+ breast cancer that has spread to the brain and determine whether cancer in the brain takes up trastuzumab, which may predict for response to trastuzumab deruxtecan (the standard of care chemotherapy).
Recruiting3 awards Phase 415 criteria
Immunotherapy + Hormone Therapy
for Advanced Breast Cancer
This phase II trial studies how well pembrolizumab works when given together with endocrine therapy and palbociclib in treating postmenopausal patients with newly diagnosed stage IV estrogen receptor positive breast cancer that has spread to other parts of the body (metastatic). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Estrogen can cause the growth of breast cancer cells. Fulvestrant blocks the use of estrogen by the tumor cells. Letrozole lowers the amount of estrogen made by the body. This may help stop the growth of tumor cells that need estrogen to grow. Palbociclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving pembrolizumab, palbociclib, and letrozole or fulvestrant may be an effective treatment for patients with stage IV estrogen receptor positive breast cancer.
Recruiting3 awards Phase 216 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at City of Hope Comprehensive Cancer Center?
City of Hope Comprehensive Cancer Center is a medical facility located in Duarte, California. This center is recognized for care of Cancer, Lymphoma, Leukemia, Tumors, Breast Cancer and other specialties. City of Hope Comprehensive Cancer Center is involved with conducting 2,114 clinical trials across 1,082 conditions. There are 153 research doctors associated with this hospital, such as Daneng Li, MD, Anna Pawlowska, MD, Mark Agulnik, and Abhishek Tripathi, MD.
Where is City of Hope Comprehensive Cancer Center located?
**City of Hope Comprehensive Cancer Center**
- **Location:** 1500 E Duarte Rd, Duarte, CA
- **Accessibility:** Conveniently accessible from the 210 Freeway, near the intersection of Duarte Road and Royal Oaks Drive.
Who should I call to ask about financial aid or insurance network?
**City of Hope Comprehensive Cancer Center Financial and Insurance Assistance Services:**
- **Financial Counselors:** Offer financial counseling, benefits explanation, out-of-pocket cost estimates, insurance authorization, and medical necessity screening.
- **Patient Resource Coordinator:** Provides financial assistance, transportation, healthcare referrals. Contact: 626-256-4673, ext. 32273.
- **Clinical Social Workers:** Assist with financial benefit guidance, including state and social security disability, and paid family leave benefits.
- **Sheri & Les Biller Patient and Family Resource Center:** A central hub for support services, offering resources to empower patients throughout their treatment.
- **Cancer Legal Resource Center (CLRC):** Offers education and support on employment, healthcare access, government benefits, medical leave, and estate planning.
**Financial Assistance Application:**
Patients can apply for financial assistance at any stage of their treatment. The application process involves completing a Financial Evaluation Form with the help of Financial Support Services Counselors and submitting necessary documentation. Pre-screening requests can be made by calling (844) 936-4673. Applications can also be initiated via the patient portal.
What insurance does City of Hope Comprehensive Cancer Center accept?
The City of Hope Comprehensive Cancer Center accepts a variety of insurance plans, including PPO, Covered California, HMO, and Medicare. For Covered California, it accepts Blue Shield of California EPO/PPO and OSCAR Health Plan of California EPO at all levels for services at their clinical network locations, though OSCAR Health Plan - City of Hope Medical Center in Duarte is out-of-network. For accurate estimates, contact their financial counselors at (833) 915-4673.
What awards or recognition has City of Hope Comprehensive Cancer Center received?
City of Hope Comprehensive Cancer Center, located in Duarte, California, is a National Cancer Institute-designated comprehensive cancer center, recognized for its excellence in cancer treatment, research, and expertise. It is a founding member of the National Comprehensive Cancer Network, showcasing its leadership in cancer research and treatment advancements. Consistently ranked among the top cancer centers in the United States by U.S. News & World Report, it has secured a position in the top 10 for the past two years.